Active, not recruitingNCT05046717
Improvement of Immunologic and Molecular Techniques for the Diagnosis and Follow-up of Patients With Thrombotic Thrombocytopenic Purpura
Studying Immune-mediated thrombotic thrombocytopenic purpura
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Fundación Española de Hematología y Hemoterapía
- Intervention
- ADAMTS13 Activity Assays(device)
- Enrollment
- 500 enrolled
- Eligibility
- 0-99 years · All sexes
- Timeline
- 2022 – 2026
Study locations (6)
- Centro Hospitalar e Universitario de Coimbra, Coimbra, Coimbra District, Portugal
- Complejo Hospitalario Universitario A Coruña, A Coruña, A Coruña, Spain
- Hospital Clinic de Barcelona, Barcelona, Spain
- Hospital Clínico San Carlos, Madrid, Spain
- Hospital Gregorio Marañon, Madrid, Spain
- Hospital La Fe de Valencia, Valencia, Spain
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05046717 on ClinicalTrials.govOther trials for Immune-mediated thrombotic thrombocytopenic purpura
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE2NCT06831058A Pilot Study of Efgartigimod for Immune-mediated Thrombotic Thrombocytopenic Purpura (iTTP)University of Minnesota
- ACTIVE NOT RECRUITINGNCT04985318Retrospective Analysis of the Efficiency of Caplacizumab in the Treatment of aTTPUniversity of Cologne
See all trials for Immune-mediated thrombotic thrombocytopenic purpura →